FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138620982> ?p ?o ?g. }

• W2138620982 endingPage "609" @default.
• W2138620982 startingPage "602" @default.
• W2138620982 abstract "The enzyme 4-oxalocrotonate tautomerase (4-OT) is part of a catabolic pathway for aromatic hydrocarbons in Pseudomonas putida mt-2, where it catalyzes the conversion of 2-hydroxy-2,4-hexadienedioate(1) to 2-oxo-3-hexenedioate(2). 4-OT is a member of the tautomerase superfamily, a group of homologous proteins that are characterized by a β-α-β structural fold and a catalytic amino-terminal proline. In the mechanism of 4-OT, Pro1 is a general base that abstracts the 2-hydroxyl proton of 1 for delivery to the C-5 position to yield 2. Here, 4-OT was explored for nucleophilic catalysis based on the mechanistic reasoning that its Pro1 residue has the correct protonation state (pK(a) ∼6.4) to be able to act as a nucleophile at pH 7.3. By using inhibition studies and mass spectrometry experiments it was first demonstrated that 4-OT can use Pro1 as a nucleophile to form an imine/enamine with various aldehyde and ketone compounds. The chemical potential of the smallest enamine (generated from acetaldehyde) was then explored for further reactions by using a small set of selected electrophiles. This systematic screening approach led to the discovery of a new promiscuous activity in wild-type 4-OT: the enzyme catalyzes the aldol condensation of acetaldehyde with benzaldehyde to form cinnamaldehyde. This low-level aldolase activity can be improved 16-fold with a single point mutation (L8R) in 4-OT's active site. The proposed mechanism of the reaction mimicks that used by natural class-I aldolases and designed catalytic aldolase antibodies. An important difference, however, is that these natural and designed aldolases use the primary amine of a lysine residue to form enamines with carbonyl substrates, whereas 4-OT uses the secondary amine of an active-site proline as the nucleophile catalyst. Further systematic screening of 4-OT and related proline-based biocatalysts might prove to be a useful approach to discover new promiscuous carbonyl transformation activities that could be exploited to develop new biocatalysts for carbon-carbon bond formation." @default.
• W2138620982 created "2016-06-24" @default.
• W2138620982 creator A5006246608 @default.
• W2138620982 creator A5015832633 @default.
• W2138620982 creator A5066997503 @default.
• W2138620982 creator A5081968907 @default.
• W2138620982 date "2011-02-03" @default.
• W2138620982 modified "2023-10-18" @default.
• W2138620982 title "Systematic Screening for Catalytic Promiscuity in 4-Oxalocrotonate Tautomerase: Enamine Formation and Aldolase Activity" @default.
• W2138620982 cites W1525251521 @default.
• W2138620982 cites W1557707972 @default.
• W2138620982 cites W1965220194 @default.
• W2138620982 cites W1969518814 @default.
• W2138620982 cites W1972722145 @default.
• W2138620982 cites W1975182459 @default.
• W2138620982 cites W1975410532 @default.
• W2138620982 cites W1981029910 @default.
• W2138620982 cites W1981249397 @default.
• W2138620982 cites W1987867414 @default.
• W2138620982 cites W1988861748 @default.
• W2138620982 cites W1993567114 @default.
• W2138620982 cites W2000297152 @default.
• W2138620982 cites W2005415277 @default.
• W2138620982 cites W2008921808 @default.
• W2138620982 cites W2011685425 @default.
• W2138620982 cites W2024722087 @default.
• W2138620982 cites W2034621209 @default.
• W2138620982 cites W2034971990 @default.
• W2138620982 cites W2048783098 @default.
• W2138620982 cites W2056296814 @default.
• W2138620982 cites W2061378257 @default.
• W2138620982 cites W2062265609 @default.
• W2138620982 cites W2068815231 @default.
• W2138620982 cites W2076412028 @default.
• W2138620982 cites W2077680621 @default.
• W2138620982 cites W2078066804 @default.
• W2138620982 cites W2094342959 @default.
• W2138620982 cites W2098485753 @default.
• W2138620982 cites W2100434441 @default.
• W2138620982 cites W2110198171 @default.
• W2138620982 cites W2118312031 @default.
• W2138620982 cites W2132547201 @default.
• W2138620982 cites W2135900956 @default.
• W2138620982 cites W2142962510 @default.
• W2138620982 cites W2158818864 @default.
• W2138620982 cites W4234732727 @default.
• W2138620982 cites W4255145826 @default.
• W2138620982 doi "https://doi.org/10.1002/cbic.201000633" @default.
• W2138620982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21290551" @default.
• W2138620982 hasPublicationYear "2011" @default.
• W2138620982 type Work @default.
• W2138620982 sameAs 2138620982 @default.
• W2138620982 citedByCount "44" @default.
• W2138620982 countsByYear W21386209822012 @default.
• W2138620982 countsByYear W21386209822013 @default.
• W2138620982 countsByYear W21386209822014 @default.
• W2138620982 countsByYear W21386209822015 @default.
• W2138620982 countsByYear W21386209822016 @default.
• W2138620982 countsByYear W21386209822017 @default.
• W2138620982 countsByYear W21386209822019 @default.
• W2138620982 countsByYear W21386209822020 @default.
• W2138620982 countsByYear W21386209822021 @default.
• W2138620982 countsByYear W21386209822022 @default.
• W2138620982 countsByYear W21386209822023 @default.
• W2138620982 crossrefType "journal-article" @default.
• W2138620982 hasAuthorship W2138620982A5006246608 @default.
• W2138620982 hasAuthorship W2138620982A5015832633 @default.
• W2138620982 hasAuthorship W2138620982A5066997503 @default.
• W2138620982 hasAuthorship W2138620982A5081968907 @default.
• W2138620982 hasConcept C104317684 @default.
• W2138620982 hasConcept C161790260 @default.
• W2138620982 hasConcept C178790620 @default.
• W2138620982 hasConcept C178907741 @default.
• W2138620982 hasConcept C181199279 @default.
• W2138620982 hasConcept C185592680 @default.
• W2138620982 hasConcept C2776378156 @default.
• W2138620982 hasConcept C2777738585 @default.
• W2138620982 hasConcept C2780631447 @default.
• W2138620982 hasConcept C28165981 @default.
• W2138620982 hasConcept C41183919 @default.
• W2138620982 hasConcept C550995028 @default.
• W2138620982 hasConcept C55493867 @default.
• W2138620982 hasConcept C71240020 @default.
• W2138620982 hasConceptScore W2138620982C104317684 @default.
• W2138620982 hasConceptScore W2138620982C161790260 @default.
• W2138620982 hasConceptScore W2138620982C178790620 @default.
• W2138620982 hasConceptScore W2138620982C178907741 @default.
• W2138620982 hasConceptScore W2138620982C181199279 @default.
• W2138620982 hasConceptScore W2138620982C185592680 @default.
• W2138620982 hasConceptScore W2138620982C2776378156 @default.
• W2138620982 hasConceptScore W2138620982C2777738585 @default.
• W2138620982 hasConceptScore W2138620982C2780631447 @default.
• W2138620982 hasConceptScore W2138620982C28165981 @default.
• W2138620982 hasConceptScore W2138620982C41183919 @default.
• W2138620982 hasConceptScore W2138620982C550995028 @default.
• W2138620982 hasConceptScore W2138620982C55493867 @default.
• W2138620982 hasConceptScore W2138620982C71240020 @default.
• W2138620982 hasIssue "4" @default.

• next